Dr Reddy's Labs

{
  "main_header": {
    "sid": 734514,
    "name": "Dr Reddy's Labs",
    "stock_name": "Dr Reddy's Labs",
    "full_name": "Dr Reddys Laboratories Ltd",
    "name_url": "stocks-analysis/dr-reddy-s-labs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,235.40",
    "chg": 52.9,
    "chgp": "4.47%",
    "dir": 1,
    "prev_price": "1,182.50",
    "mcapval": "102,192.00 Cr",
    "mcap": "Large Cap",
    "scripcode": "500124",
    "symbol": "DRREDDY",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE089A01031",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "15.72 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-reddy-s-labs-734514-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Reddys Laboratories Ltd Opens Strong with 7.33% Gap Up Amid Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-opens-strong-with-733-gap-up-amid-positive-market-sentiment-3817936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DrReddysLaborat_gapup_3817936.png",
        "date": "2026-02-03 09:57:00",
        "description": "Dr Reddys Laboratories Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a significant gap up of 7.33%, reflecting positive market sentiment within the Pharmaceuticals & Biotechnology sector. The stock outperformed both its sector and the broader Sensex index, signalling renewed momentum after a brief period of decline."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Hits Intraday High with 3.56% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-hits-intraday-high-with-356-surge-on-3-feb-2026-3817679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DrReddysLaborat_priceRelatedfactors_3817679.png",
        "date": "2026-02-03 09:41:54",
        "description": "Dr Reddys Laboratories Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 1269.05, marking a 7.33% gain from the previous close. The stock outperformed its sector and broader market indices, reflecting notable trading momentum during the session."
      },
      {
        "title": "Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Volatile Market Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-navigating-nifty-50-membership-amid-volatile-market-moves-3817448",
        "imagepath": "",
        "date": "2026-02-03 09:23:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable advantages and responsibilities on Dr Reddys Laboratories Ltd. As one of the 50 largest and most liquid stocks on the National Stock Exchange of India, the company benefits from enhanced visibility among domestic and international investors. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are mandated to hold shares of Dr Reddys Laboratories, ensuring a steady demand irrespective of short-term market fluctuations.</p>\n                <p>This membership also subjects the stock to rigorous scrutiny, with performance often benchmarked against the broader index. Dr Reddys Laboratories’ market capitalisation currently stands at a substantial ₹..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Faces Downgrade Amidst Mixed Market Performance and Nifty 50 Membership Significance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-faces-downgrade-amidst-mixed-market-performance-and-nifty-50-membership-significance-3815891",
        "imagepath": "",
        "date": "2026-02-02 09:20:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Significance</strong></p>\n                <p>As a key member of the Nifty 50, Dr Reddys Laboratories Ltd holds considerable influence on the benchmark’s overall performance, particularly within the Pharmaceuticals & Biotechnology sector. The company’s market capitalisation stands at a robust ₹99,149.91 crores, underscoring its stature as a large-cap stock. Its inclusion in the index not only attracts passive fund flows from index-tracking funds but also places it under the scrutiny of institutional investors who closely monitor sectoral and market-wide trends.</p>\n                <p>However, the stock’s recent performance has been underwhelming relative to the Sensex and sector peers. Over the past year, Dr Reddys Laboratories has recorded a decline..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Faces Sell Grade Amid Mixed Performance and Nifty 50 Membership Impact",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-faces-sell-grade-amid-mixed-performance-and-nifty-50-membership-impact-3813878",
        "imagepath": "",
        "date": "2026-02-01 09:20:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable prestige and investment inflows for Dr Reddys Laboratories Ltd. The index membership ensures enhanced visibility among domestic and global institutional investors, often translating into higher liquidity and a more stable shareholder base. However, this status also brings heightened expectations regarding financial performance and corporate governance.</p>\n                <p>Dr Reddys, with a market capitalisation of ₹1,01,666.32 crores, is categorised as a large-cap stock, making it a key component of the index’s Pharmaceuticals & Biotechnology sector representation. The company’s inclusion in the Nifty 50 means that passive funds tracking the index must h..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Faces Headwinds Amid Nifty 50 Membership and Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-faces-headwinds-amid-nifty-50-membership-and-institutional-shifts-3810794",
        "imagepath": "",
        "date": "2026-01-30 09:21:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a member of the Nifty 50, Dr Reddys Laboratories Ltd holds a pivotal role in India's benchmark equity index, which represents the top 50 companies by free-float market capitalisation on the National Stock Exchange. Inclusion in this index not only enhances the stock's visibility among domestic and international investors but also ensures substantial passive fund inflows from index-tracking mutual funds and exchange-traded funds (ETFs). This status typically provides a degree of price support and liquidity, making the stock a preferred choice for large institutional portfolios.</p>\n                <p>However, membership also brings heightened scrutiny and expectations. Dr Reddys Laboratories Ltd's recent per..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Faces Sell Downgrade Amid Nifty 50 Membership Significance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-faces-sell-downgrade-amid-nifty-50-membership-significance-3808937",
        "imagepath": "",
        "date": "2026-01-29 09:20:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a key component of the Nifty 50 index, Dr Reddys Laboratories Ltd holds a critical position in India’s equity market landscape. Inclusion in this benchmark index not only enhances the stock’s visibility among domestic and international investors but also ensures substantial liquidity and institutional interest. The company’s market capitalisation stands at a robust ₹1,00,581.30 crores, categorising it firmly as a large-cap stock. This stature typically attracts passive funds tracking the Nifty 50, thereby providing a degree of price support and stability.</p>\n                <p>However, the recent performance metrics indicate that Dr Reddys is struggling to maintain its momentum. The stock has declined by 1..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-navigating-nifty-50-membership-amid-institutional-shifts-3806945",
        "imagepath": "",
        "date": "2026-01-28 09:21:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership: A Double-Edged Sword</strong></p>\n                <p>Being part of the Nifty 50 index confers Dr Reddys Laboratories Ltd a prestigious status, reflecting its market capitalisation, liquidity, and sector representation. With a market cap of ₹1,03,602.67 crores, it firmly sits among India’s large-cap elite. This membership ensures substantial passive fund inflows, as index-tracking funds and ETFs allocate capital in line with the index composition. However, it also subjects the stock to heightened scrutiny and volatility linked to broader index movements.</p>\n                <p>Dr Reddys’ current valuation metrics reveal a price-to-earnings (P/E) ratio of 18.59, notably below the Pharmaceuticals & Biotechnology sector average of 32.47. This discount suggests th..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-navigating-nifty-50-membership-amid-institutional-shifts-3805066",
        "imagepath": "",
        "date": "2026-01-27 09:20:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50, Dr Reddys Laboratories Ltd holds a critical position within India’s premier equity benchmark. Inclusion in this index not only reflects the company’s market capitalisation and liquidity but also ensures substantial institutional interest, particularly from index funds and passive investors. The stock’s market cap currently stands at a robust ₹1,04,036.67 crores, categorising it firmly as a large-cap entity within the Pharmaceuticals & Biotechnology sector.</p>\n                <p>Being part of the Nifty 50 means Dr Reddys is often a bellwether for sectoral and broader market trends. Its performance can influence the sectoral index and, by extension, the overall market sentiment..."
      }
    ],
    "total": 461,
    "sid": "734514",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-reddys-laboratories-734514"
  },
  "announcements": [
    {
      "details": "Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions for the period ended September 30, 2019.",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 22, 2019, titled \"Dr. Reddy's Laboratories announces launch of",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Press Release",
      "datetime": "22-Nov-2019"
    },
    {
      "details": "Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Dr. Reddy s Laboratories enters Nutrition Segment with Celevida in India.\".",
      "source": "NSE",
      "caption": "Dr. Reddy's Laboratories Limited - Press Release",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has declared <strong>800%</strong> dividend, ex-date: 10 Jul 25",
          "dt": "2025-07-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:5</strong> stock split, ex-date: 28 Oct 24",
          "dt": "2024-10-28",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 28 Aug 06",
          "dt": "2006-08-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Reddys Laboratories Ltd Opens Strong with 7.33% Gap Up Amid Positive Market Sentiment

2026-02-03 09:57:00

Dr Reddys Laboratories Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a significant gap up of 7.33%, reflecting positive market sentiment within the Pharmaceuticals & Biotechnology sector. The stock outperformed both its sector and the broader Sensex index, signalling renewed momentum after a brief period of decline.

Read full news article

Dr Reddys Laboratories Ltd Hits Intraday High with 3.56% Surge on 3 Feb 2026

2026-02-03 09:41:54

Dr Reddys Laboratories Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 1269.05, marking a 7.33% gain from the previous close. The stock outperformed its sector and broader market indices, reflecting notable trading momentum during the session.

Read full news article

Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Volatile Market Moves

2026-02-03 09:23:13

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable advantages and responsibilities on Dr Reddys Laboratories Ltd. As one of the 50 largest and most liquid stocks on the National Stock Exchange of India, the company benefits from enhanced visibility among domestic and international investors. Index funds and exchange-traded funds (ETFs) tracking the Nifty 50 are mandated to hold shares of Dr Reddys Laboratories, ensuring a steady demand irrespective of short-term market fluctuations.

This membership also subjects the stock to rigorous scrutiny, with performance often benchmarked against the broader index. Dr Reddys Laboratories’ market capitalisation currently stands at a substantial ₹...

Read full news article

Dr Reddys Laboratories Ltd Faces Downgrade Amidst Mixed Market Performance and Nifty 50 Membership Significance

2026-02-02 09:20:32

Index Membership and Market Significance

As a key member of the Nifty 50, Dr Reddys Laboratories Ltd holds considerable influence on the benchmark’s overall performance, particularly within the Pharmaceuticals & Biotechnology sector. The company’s market capitalisation stands at a robust ₹99,149.91 crores, underscoring its stature as a large-cap stock. Its inclusion in the index not only attracts passive fund flows from index-tracking funds but also places it under the scrutiny of institutional investors who closely monitor sectoral and market-wide trends.

However, the stock’s recent performance has been underwhelming relative to the Sensex and sector peers. Over the past year, Dr Reddys Laboratories has recorded a decline...

Read full news article

Dr Reddys Laboratories Ltd Faces Sell Grade Amid Mixed Performance and Nifty 50 Membership Impact

2026-02-01 09:20:58

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable prestige and investment inflows for Dr Reddys Laboratories Ltd. The index membership ensures enhanced visibility among domestic and global institutional investors, often translating into higher liquidity and a more stable shareholder base. However, this status also brings heightened expectations regarding financial performance and corporate governance.

Dr Reddys, with a market capitalisation of ₹1,01,666.32 crores, is categorised as a large-cap stock, making it a key component of the index’s Pharmaceuticals & Biotechnology sector representation. The company’s inclusion in the Nifty 50 means that passive funds tracking the index must h...

Read full news article

Dr Reddys Laboratories Ltd Faces Headwinds Amid Nifty 50 Membership and Institutional Shifts

2026-01-30 09:21:08

Significance of Nifty 50 Membership

As a member of the Nifty 50, Dr Reddys Laboratories Ltd holds a pivotal role in India's benchmark equity index, which represents the top 50 companies by free-float market capitalisation on the National Stock Exchange. Inclusion in this index not only enhances the stock's visibility among domestic and international investors but also ensures substantial passive fund inflows from index-tracking mutual funds and exchange-traded funds (ETFs). This status typically provides a degree of price support and liquidity, making the stock a preferred choice for large institutional portfolios.

However, membership also brings heightened scrutiny and expectations. Dr Reddys Laboratories Ltd's recent per...

Read full news article

Dr Reddys Laboratories Ltd Faces Sell Downgrade Amid Nifty 50 Membership Significance

2026-01-29 09:20:58

Significance of Nifty 50 Membership

As a key component of the Nifty 50 index, Dr Reddys Laboratories Ltd holds a critical position in India’s equity market landscape. Inclusion in this benchmark index not only enhances the stock’s visibility among domestic and international investors but also ensures substantial liquidity and institutional interest. The company’s market capitalisation stands at a robust ₹1,00,581.30 crores, categorising it firmly as a large-cap stock. This stature typically attracts passive funds tracking the Nifty 50, thereby providing a degree of price support and stability.

However, the recent performance metrics indicate that Dr Reddys is struggling to maintain its momentum. The stock has declined by 1...

Read full news article

Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Institutional Shifts

2026-01-28 09:21:01

Index Membership: A Double-Edged Sword

Being part of the Nifty 50 index confers Dr Reddys Laboratories Ltd a prestigious status, reflecting its market capitalisation, liquidity, and sector representation. With a market cap of ₹1,03,602.67 crores, it firmly sits among India’s large-cap elite. This membership ensures substantial passive fund inflows, as index-tracking funds and ETFs allocate capital in line with the index composition. However, it also subjects the stock to heightened scrutiny and volatility linked to broader index movements.

Dr Reddys’ current valuation metrics reveal a price-to-earnings (P/E) ratio of 18.59, notably below the Pharmaceuticals & Biotechnology sector average of 32.47. This discount suggests th...

Read full news article

Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Institutional Shifts

2026-01-27 09:20:57

Significance of Nifty 50 Membership

As a constituent of the Nifty 50, Dr Reddys Laboratories Ltd holds a critical position within India’s premier equity benchmark. Inclusion in this index not only reflects the company’s market capitalisation and liquidity but also ensures substantial institutional interest, particularly from index funds and passive investors. The stock’s market cap currently stands at a robust ₹1,04,036.67 crores, categorising it firmly as a large-cap entity within the Pharmaceuticals & Biotechnology sector.

Being part of the Nifty 50 means Dr Reddys is often a bellwether for sectoral and broader market trends. Its performance can influence the sectoral index and, by extension, the overall market sentiment...

Read full news article

View All News